Pfizer: Hypercholesterolemia trials
The registry lists 17 Hypercholesterolemia studies with Pfizer as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 11Phase 2 4Phase 3 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese SubjectsCompletedNCT02055976Phase 2Results posted
- Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper ArmCompletedNCT02043301Phase 1Results posted
- Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A StatinCompletedNCT01592240Phase 2Results posted
- A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With HypercholesterolemiaCompletedNCT01435382Phase 1Results posted
- A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of StatinsCompletedNCT01350141Phase 2Results posted
- A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of StatinsCompletedNCT01342211Phase 2Results posted
- Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With HypercholesterolemiaCompletedNCT01243151Phase 1Results posted
- Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With AtorvastatinCompletedNCT01163851Phase 1Results posted
- Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human HyaluronidaseTerminatedNCT02667223Phase 1
- Single Dose Study of PF-06815345 in Healthy SubjectsTerminatedNCT02654899Phase 1
- A Multiple Dose Study Of PF-06678552 In Healthy SubjectsCompletedNCT02079922Phase 1
- A Single Dose Study Of PF-06678552 In Healthy SubjectsCompletedNCT01992614Phase 1
- A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic SubjectsCompletedNCT01720537Phase 1
- Multiple-Dose Safety Study Of RN316 For TheTreatment Of HypercholesterolemiaWithdrawnNCT01163838Phase 1
- A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult SubjectsCompletedNCT00991159Phase 1
- A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).TerminatedNCT00267280Phase 3
- A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.CompletedNCT00267254Phase 3